Research Grade Tabalumab ( 他贝芦单抗 )
- 发布日期： 2020-10-28
- 更新日期： 2025-10-24
产品详请
| 产地 |
中国
|
| 品牌 |
Chemstan
|
| 货号 |
CSD00267
|
| 保存条件 |
store at -80℃
|
| 用途 |
仅用于科研用途
|
| 应用范围 |
|
| 抗原来源 |
CHO cells
|
| CAS编号 |
1143503-67-6
|
| 保质期 |
一年
|
| 抗体名 |
Tabalumab ( 他贝芦单抗 )
|
| 是否单克隆 |
|
| 克隆性 |
|
| 靶点 |
TNFSF13B/CD257[Homo sapiens]
|
| 适应物种 |
|
| 形态 |
|
| 宿主 |
|
| 标记物 |
|
| 包装规格 |
1mg/ml
|
| 纯度 |
%
|
| 亚型 |
|
| 标识物 |
|
| 浓度 |
95%
|
| 免疫原 |
|
| 是否进口 |
否
|
Tabalumab has been used in trials studying the treatment of Autoimmune Disease, Rheumatoid Arthritis, Kidney Failure, Chronic, Connective Tissue Disease, and Systemic Lupus Erythematosus, among others.
货号（Catalog No.）
CSD00267
通用名INN
Tabalumab
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
生物活性
产品描述(Description)
Tabalumab has been used in trials studying the treatment of Autoimmune Disease, Rheumatoid Arthritis, Kidney Failure, Chronic, Connective Tissue Disease, and Systemic Lupus Erythematosus, among others.
别名(Alternative names)
LY2127399
靶点;物种(Specificity target name;species)
TNFSF13B/CD257[Homo sapiens]
活性研究（体外/体内研究）(Activity in vitro)
The ED50 is <20 ng/mL as measured by human RPMI 8226 cells, corresponding to a specific activity of >5.0 × 10^4 units/mg.
种类(Species)
Homo sapiens
受体鉴定(Receptor identification)
IgG4-kappa
化学信息
CAS
1143503-67-6
存储条件(Storage)
store at -80°C
Note
For research use only. Not suitable for clinical or therapeutic use.
